Lene Jespersen

Lene Jespersen

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
PSPrathapkumar Halady Shetty
Prathapkumar Halady Shetty
LJLene Jespersen
Lene Jespersen

1 October 2013 in Food Microbiology
Verified
Journal Article
Closed access
CRCíntia Lacerda Ramos
Cíntia Lacerda Ramos
LTLine Thorsen
Line Thorsen
RSRosane Freitas Schwan
Rosane Freitas Schwan
LJLene Jespersen
Lene Jespersen

7 September 2011 in British Journal of Nutrition
Verified
Journal Article
Closed access
GRGiuliano Rizzardini
Giuliano Rizzardini
DEDorte Eskesen
Dorte Eskesen
PCPhilip Calder
Philip Calder
ACAmedeo Capetti
Amedeo Capetti
LJLene Jespersen
Lene Jespersen
mario clericimario clerici
mario clerici
The present study investigated the ability of Bifidobacterium animalis ssp. lactis (BB-12®) and Lactobacillus paracasei ssp. paracasei (L. casei 431®) to modulate the immune system using a vaccination model in healthy subjects. A randomised, double-blind, placebo-controlled, parallel-group study was conducted in 211 subjects (56 % females, mean age 33·2 (sd 13·1) years). Subjects consumed a minimum of 109 colony-forming units of BB-12® (capsule) or L. casei 431® (dairy drink) or a matching placebo once daily for 6 weeks. After 2 weeks, a seasonal influenza vaccination was given. Plasma and saliva samples were collected at baseline and after 6 weeks for the analysis of antibodies, cytokines and innate immune parameters. Changes from baseline in vaccine-specific plasma IgG, IgG1 and IgG3 were significantly greater in both probiotic groups v. the corresponding placebo group (L. casei 431®, P = 0·01 for IgG; P < 0·001 for remaining comparisons). The number of subjects obtaining a substantial increase in specific IgG (defined as ≥ 2-fold above baseline) was significantly greater in both probiotic groups v. placebo (BB-12®, P < 0·001 for IgG, IgG1 and IgG3; L. casei 431®, P < 0·001 for IgG1 and IgG3). Significantly greater mean fold increases for vaccine-specific secretory IgA in saliva were observed in both probiotic groups v. placebo (BB-12®, P = 0·017; L. casei 431®, P = 0·035). Similar results were observed for total antibody concentrations. No differences were found for plasma cytokines or innate immune parameters. Data herein show that supplementation with BB-12® or L. casei 431® may be an effective means to improve immune function by augmenting systemic and mucosal immune responses to challenge.

1 April 2010 in Nutrients
Verified
Journal Article
Open access
PDF file
SMSaloomeh Moslehi-Jenabian
Saloomeh Moslehi-Jenabian
LLLine Lindegaard
Line Lindegaard
LJLene Jespersen
Lene Jespersen
Besides being important in the fermentation of foods and beverages, yeasts have shown numerous beneficial effects on human health. Among these, probiotic effects are the most well known health effects including prevention and treatment of intestinal diseases and immunomodulatory effects. Other beneficial functions of yeasts are improvement of bioavailability of minerals through the hydrolysis of phytate, folate biofortification and detoxification of mycotoxins due to surface binding to the yeast cell wall.

1 February 2005 in FEMS Yeast Research
Verified
Journal Article
Closed access
LJLene Jespersen
Lene Jespersen
DND Nielsen
D Nielsen
SHS Honholt
S Honholt
MJM Jakobsen
M Jakobsen
Samples of cocoa beans were taken on two separate occasions during heap and tray fermentations in Ghana, West Africa. In total 496 yeast isolates were identified by conventional microbiological analyses and by amplification of their ITS1-5.8S rDNA-ITS2 regions. For important species the identifications were confirmed by sequencing of the D1/D2 domain of the 5' end of the large subunit (26S) rDNA. Assimilations of organic acids and other carbon compounds were conducted. For dominant yeasts intraspecies variations were examined by determination of chromosome length polymorphism (CLP) using pulsed-field gel electrophoresis. For the heap fermentations maximum yeast cell counts of 9.1 x 10(7) were reached, whereas maximum yeast counts of 6.0 x 10(6) were reached for the tray fermentations. Candida krusei was found to be the dominant species during heap fermentation, followed by P. membranifaciens, P. kluyveri, Hanseniaspora guilliermondii and Trichosporon asahii, whereas Saccharomyces cerevisiae and P. membranifaciens were found to be the dominant species during tray fermentation followed by low numbers of C. krusei, P. kluyveri, H. guilliermondii and some yeast species of minor importance. For isolates within all dominant species CLP was evident, indicating that several different strains are involved in the fermentations. Isolates of C. krusei, P. membranifaciens, H. guilliermondii, T. asahii and Rhodotorula glutinis could be found on the surface of the cocoa pods and in some cases on the production equipment, whereas the origin of e.g. S. cerevisiae was not indicated by the results obtained. In conclusion, the results obtained show that fermentation of cocoa beans is a very inhomogeneous process with great variations in both yeast counts and species composition. The variations seem to depend especially on the processing procedure, but also the season and the post-harvest storage are likely to influence the yeast counts and the species composition.

1 January 2007 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
PSPrathapkumar Halady Shetty
Prathapkumar Halady Shetty
BHBenedicte Hald
Benedicte Hald
LJLene Jespersen
Lene Jespersen